Page 291 - The Toxicology of Fishes
P. 291

Receptor-Mediated Mechanisms of Toxicity                                    271


                       Tarrant, A. M., Greytak, S. R., Callard, G. V., and Hahn, M. E. (2006). Estrogen receptor-related receptors in
                          the killifish Fundulus heteroclitus: diversity, expression, and estrogen responsiveness. J. Mol. Endocrinol.,
                          37, 105–120.
                       Taylor, J. S., Van de Peer, Y., Braasch, I., and Meyer, A. (2001). Comparative genomics provides evidence for
                          an ancient genome duplication event in fish. Phil. Trans. R. Soc. Lond. B, 356, 1661–1679.
                       Tchoudakova,  A. and Callard, G.  V. (1998). Identification of multiple CYP19 genes encoding different
                          cytochrome P450 aromatase isozymes in brain and ovary. Endocrinology, 139, 2179–2189.
                       Teraoka, H., Dong, W., Tsujimoto, Y., Iwasa, H., Endoh, D. et al. (2003). Induction of cytochrome P450 1A
                          is required for circulation failure and edema by 2,3,7,8-tetrachlorodibenzo-p-dioxin in zebrafish. Biochem.
                          Biophys. Res. Commun., 304, 223–228.
                       Thornton, J. W. (2001). Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand
                          exploitation and serial genome expansions. Proc. Natl. Acad. Sci. U.S.A., 98, 5671–5676.
                       Thorpe, K. L., Gross-Sorokin, M., Johnson, I., Brighty, G., and Tyler, C. R. (2006). An assessment of the
                          model of concentration addition for predicting the estrogenic activity of chemical mixtures in wastewater
                          treatment works effluents. Environ. Health Perspect., 114(Suppl. 1), 90–97.
                       Ton, C., Stamatiou, D., Dzau, V. J., and Liew, C. C. (2002). Construction of a zebrafish cDNA microarray:
                          gene expression profiling of the zebrafish during development. Biochem. Biophys. Res. Commun., 296,
                          1134–1142.
                       Topczewska, J. M., Topczewski, J., Shostak, A., Kume, T., Solnica-Krezel, L., and Hogan, B. L. (2001). The
                          winged helix transcription factor Foxc1a is essential for somitogenesis in zebrafish.  Genes Dev., 15,
                          2483–2493.
                       Tsui, H. W. and Okey, A. B. (1981). Rapid vertical tube rotor gradient assay for binding of 2,3,7,8-tetrachloro-
                          dibenzo-p-dioxin to the Ah receptor. Can. J. Physiol. Pharmacol., 59, 927–931.
                       Udvadia, A. J. and Linney, E. (2003). Windows into development: historic, current, and future perspectives
                          on transgenic zebrafish. Dev. Biol., 256, 1–17.
                       van der Ven, K., De Wit, M., Keil, D., Moens, L., Van Leemput, K. et al. (2005). Development and application
                          of a brain-specific cDNA microarray for effect evaluation of neuro-active pharmaceuticals in zebrafish
                          (Danio rerio). Comp. Biochem. Physiol. B Biochem. Mol. Biol., 141, 408–417.
                       van der Ven, L. T., van den Brandhof, E. J., Vos, J. H., Power, D. M., and Wester, P. W. (2006). Effects of the
                          antithyroid agent propylthiouracil in a partial life cycle assay with zebrafish. Environ. Sci. Technol., 40,
                          74–81.
                       Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. (1995). Serial analysis of gene expression.
                          Science, 270, 484–487.
                       Vijayan, M. M., Prunet, P., and Boone, A. N. (2005). Xenobiotic impact on corticosteroid signaling. In
                          Biochemistry and Molecular Biology of Fishes. Vol.  6.  Environmental Toxicology, Moon,  T.  W. and
                          Mommsen, T. P., Eds., Elsevier, Amsterdam, pp. 3–41.
                       Volz, D. C., Bencic, D. C., Hinton, D. E., Law, J. M., and Kullman, S. W. (2005). 2,3,7,8-Tetrachlorodibenzo-
                          p-dioxin (TCDD) induces organ- specific differential gene expression in male Japanese medaka (Oryzias
                          latipes). Toxicol Sci 85, 572–584.
                       Volz, D. C., Hinton, D. E., Law, J. M., and Kullman, S. W. (2006). Dynamic gene expression changes precede
                          dioxin-induced liver pathogenesis in medaka fish. Toxicol. Sci., 89, 524–534.
                       von Schalburg, K. R., Rise, M. L., Cooper, G. A., Brown, G. D., Gibbs, A. R., Nelson, C. C., Davidson, W.
                          S., and Koop, B. F. (2005). Fish and chips: various methodologies demonstrate utility of a 16,006–gene
                          salmonid microarray. BMC Genomics, 6, 126.
                       Vuori, K. A., Koskinen, H., Krasnov, A., Koivumaki, P., Afanasyev, S., Vuorinen, P. J., and Nikinmaa, M.
                          (2006). Developmental disturbances in early life stage mortality (M74) of Baltic salmon fry as studied
                          by changes in gene expression. BMC Genomics, 7, 56.
                       Walisser, J. A., Bunger, M. K., Glover, E., Harstad, E. B., and Bradfield, C. A. (2004). Patent ductus venosus
                          and dioxin resistance in mice harboring a hypomorphic Arnt allele. J. Biol. Chem., 279, 16326–16331.
                       Walker, C. C., Salinas, K. A., Harris, P. S., Wilkinson, S. S., Watts, J. D., and Hemmer, M. J. (2006). A
                          proteomic (SELDI-TOF-MS) approach to estrogen agonist screening. Toxicol. Sci., 95(1), 74–81.
                       Walker, M. K., Cook, P. M., Butterworth, B. C., Zabel, E. W., and Peterson, R. E. (1996). Potency of a complex
                          mixture of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners compared to 2,3,7,8-
                          tetrachlorodibenzo-p-dioxin in causing fish early life stage mortality. Fundam. Appl. Toxicol., 30, 178–186.
   286   287   288   289   290   291   292   293   294   295   296